Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors

Diffuse-type gastric carcinomas (DGC) exhibit more aggressive progression and poorer prognosis than intestinal-type and other gastric carcinomas. To identify potential therapeutic targets, we examined protein tyrosine phosphorylation in a panel of DGC and other gastric cancer cell lines. Protein tyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Hideki, Takanashi, Miho, Yoshida, Nachi, Ito, Yuumi, Kamata, Reiko, Fukami, Kiyoko, Yanagihara, Kazuyoshi, Sakai, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317844/
https://www.ncbi.nlm.nih.gov/pubmed/24612061
http://dx.doi.org/10.1111/cas.12387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317844/
https://www.ncbi.nlm.nih.gov/pubmed/24612061
http://dx.doi.org/10.1111/cas.12387

Ejemplares similares